# Taper Or Abrupt Steroid Stop: TOASSTtrial

> **NCT03153527** · PHASE4 · RECRUITING · sponsor: **University Hospital, Basel, Switzerland** · enrollment: 530 (estimated)

## Conditions studied

- Inflammatory Disorder
- Autoimmune

## Interventions

- **DRUG:** Prednisone
- **OTHER:** Placebo Arm

## Key facts

- **NCT ID:** NCT03153527
- **Lead sponsor:** University Hospital, Basel, Switzerland
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2017-05-31
- **Primary completion:** 2027-06
- **Final completion:** 2027-06
- **Target enrollment:** 530 (ESTIMATED)
- **Last updated:** 2026-04-22

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03153527

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03153527, "Taper Or Abrupt Steroid Stop: TOASSTtrial". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03153527. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*